A PhD studentship is available in the Molecular Haematology and Cancer Biology (MHCB) Unit at the Institute of Child Health, University College London and Great Ormond Street Hospital for Children.
The MHCB Unit is responsible for both basic and clinical cancer research within the joint institution.
There are over 30 research scientists and associated personnel in the Unit which was rated 5*A in the last RAE.
The laboratories are housed in the impressive Camelia Botnar Building with full access to a wide range of services including FACS core facility and Affymetrix microarray service.
The Olivia Hodson Cancer Fund PhD studentship is in Dr. Hugh Brady's group.
The project will build on previous work in the group on the biochemical basis of drug-induced senescence (Clinical Cancer Research, 11:8158-71).
The objective is to improve cancer therapy through understanding the mechanisms regulating premature senescence.
The successful candidate must have a First or Upper Second in a biological discipline, at least one year's lab experience in molecular biology-based research and preferably a higher degree qualification such as MSc or MRes.
The PhD studentship has a stipend of £16,000 in the first year with annual increments over each of the following two years.
Written applications must include a CV plus the names of two referees and should be sent to:
Molecular Haematology and Cancer Biology Unit,
Institute of Child Health,
30 Guilford Street,
or email email@example.com
Closing date: 16th April
For more information see: